The predictors of the efficacy of pharmacological cardioversion with class III antiarrhythmic drug - nibentan in patients with persistent atrial fibrillation

被引：0
|
作者：
Bregvadze, I. [1 ]
Maykov, E. [2 ]
Sokolov, S. [2 ]
Golitsyn, S. [2 ]
Rozenshtraukh, L. [2 ]
Chazov, E. [2 ]
Pagava, Z. [1 ]
机构：
[1] Ctr Vasc & Heart Dis, Cardiol, Tbilisi, Georgia
[2] Cardiol Res & Prod Ctr, Clin Electrophysiol, Moscow, Russia
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P6383
引用
收藏
页码：1374 / 1374
页数：1
相关论文
共 50 条
  • [41] First Experience of Clinical Use of New Class III Antiarrhythmic Agent Niferidil in Patients With Persistent Atrial Fibrillation and Flutter
    Yuricheva, Yu. A.
    Maykov, E. B.
    Sokolov, S. F.
    Klimenko, Yu. L.
    Kratskina, T. L.
    Tarasovskyi, G. S.
    Bildinov, O. A.
    Bakalov, S. A.
    Golitsyn, S. P.
    Beloshapko, G. G.
    Yushmanova, A. V.
    Rosenshtraukh, L. V.
    Chazov, E. I.
    KARDIOLOGIYA, 2011, 51 (01) : 55 - 64
  • [42] Efficacy and safety in pharmacological cardioversion of recent-onset atrial fibrillation: a propensity score matching to compare amiodarone vs class IC antiarrhythmic drugs
    Antonio Bonora
    Gianni Turcato
    Elena Franchi
    Gabriele Taioli
    Alice Dilda
    Germana Zerman
    Antonio Maccagnani
    Claudio Pistorelli
    Oliviero Olivieri
    Internal and Emergency Medicine, 2017, 12 : 853 - 859
  • [43] Efficacy and safety in pharmacological cardioversion of recent-onset atrial fibrillation: a propensity score matching to compare amiodarone vs class IC antiarrhythmic drugs
    Bonora, Antonio
    Turcato, Gianni
    Franchi, Elena
    Taioli, Gabriele
    Dilda, Alice
    Zerman, Germana
    Maccagnani, Antonio
    Pistorelli, Claudio
    Olivieri, Oliviero
    INTERNAL AND EMERGENCY MEDICINE, 2017, 12 (06) : 853 - 859
  • [44] Internal low energy atrial cardioversion: Efficacy and safety in older patients with chronic persistent atrial fibrillation
    Boriani, G
    Biffi, M
    Magagnoli, G
    Zannoli, R
    Branzi, A
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2001, 49 (01) : 80 - 84
  • [45] Predictors of long-term outcomes in patients with persistent atrial fibrillation undergoing electrical cardioversion
    Dehghani, Mohammad Reza
    Safarzadeh, Navideh
    Shariati, Akram
    Rezaei, Yousef
    JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH, 2024, 16 (01) : 21 - 27
  • [46] Antiarrhythmic drug initiation in patients with atrial fibrillation
    Pinski, SL
    Helguera, ME
    PROGRESS IN CARDIOVASCULAR DISEASES, 1999, 42 (01) : 75 - 90
  • [47] New Class III Antiarrhythmic Drugs for Treatment of Atrial Fibrillation
    Maykov, E. B.
    KARDIOLOGIYA, 2012, 52 (11) : 56 - 65
  • [48] Safety and Efficacy of Ibutilide for Acute Pharmacological Cardioversion of Rheumatic Atrial Fibrillation
    Shenthar, Jayaprakash
    Banavalikar, Bharatraj
    Valappil, Sanjai Pattu
    Deshpande, Saurabh
    Nireshwalia, Aparna
    Padmanabhan, Deepak
    Reddy, Sathish S.
    CARDIOLOGY, 2021, 146 (05) : 624 - 632
  • [49] A new method for internal cardioversion in patients with persistent atrial fibrillation
    周京敏
    Stefan Sack
    Frank Heinzel
    Peter Hunold
    Nicklas Dagres
    Raimund Erbel
    葛均波
    ChineseMedicalJournal, 2002, (02)
  • [50] THE TIME OF ELECTRICAL CARDIOVERSION IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION WITH HYPERTHYROIDISM
    Erdogan, E.
    Akkaya, M.
    Vatankulu, M. A.
    Bacaksiz, A.
    Goktekin, O.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 147 : S117 - S117
12345